Citigroup’s BioNTech BNTX Stock Holding History

Citigroup’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.66M	Buy	74,900 +49,900	+200%	+$5.13M	﹤0.01%	1747
2025 Q4	$2.38M	Hold	25,000	–	–	﹤0.01%	2544
2025 Q3	$2.47M	Buy	+25,000	New	+$2.67M	﹤0.01%	2506
2025 Q2	–	Sell	-24,700	Closed	-$2.25M	–	5663
2025 Q1	$2.25M	Sell	24,700 -23,100	-48%	-$2.59M	﹤0.01%	2590
2024 Q4	$5.45M	Sell	47,800 -75,200	-61%	-$8.58M	﹤0.01%	1872
2024 Q3	$14.6M	Buy	123,000 +98,100	+394%	+$9.02M	0.01%	1125
2024 Q2	$2M	Buy	+24,900	New	+$2.28M	﹤0.01%	2354
2024 Q1	–	Sell	-20,200	Closed	-$2.13M	–	5643
2023 Q4	$2.13M	Buy	+20,200	New	+$2.04M	﹤0.01%	2184
2022 Q3	–	Sell	-20,000	Closed	-$2.98M	–	5846
2022 Q2	$2.98M	Buy	+20,000	New	+$3.06M	﹤0.01%	1825
2022 Q1	–	Sell	-58,300	Closed	-$15M	–	6314
2021 Q4	$15M	Sell	58,300 -46,600	-44%	-$12.8M	0.01%	1170
2021 Q3	$28.6M	Buy	104,900 +19,900	+23%	+$6.32M	0.02%	793
2021 Q2	$19M	Buy	+85,000	New	+$16M	0.01%	1028
2021 Q1	–	Sell	-17,100	Closed	-$1.39M	–	6315
2020 Q4	$1.39M	Buy	+17,100	New	+$1.68M	﹤0.01%	3215

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup's BNTX Position: Q1 2026 in Review

Citigroup increased its BioNTech (BNTX) stake by 21% in Q1 2026, buying an estimated $5.56M and bringing the position to 310,366 shares worth $27.6M. The position accounts for 0.01% of the portfolio, ranked #907.

Citigroup first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $45.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Citigroup held 310,366 shares of BioNTech worth $27.6M as of Q1 2026.
Citigroup bought 54,141 BioNTech shares in Q1 2026, an estimated $5.56M.
BioNTech made up 0.01% of Citigroup's portfolio in Q1 2026, its #907 holding.
Citigroup first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
Citigroup's BioNTech position peaked at $45.1M in Q4 2021.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.